398 related articles for article (PubMed ID: 20401541)
1. Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.
Marshall LJ; Major EO
J Neuroimmune Pharmacol; 2010 Sep; 5(3):404-17. PubMed ID: 20401541
[TBL] [Abstract][Full Text] [Related]
2. Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy.
Seth P; Diaz F; Major EO
J Neurovirol; 2003 Apr; 9(2):236-46. PubMed ID: 12707854
[TBL] [Abstract][Full Text] [Related]
3. John Cunningham virus: an overview on biology and disease of the etiological agent of the progressive multifocal leukoencephalopathy.
Pietropaolo V; Prezioso C; Bagnato F; Antonelli G
New Microbiol; 2018 Jul; 41(3):179-186. PubMed ID: 29620790
[TBL] [Abstract][Full Text] [Related]
4. Early events in the life cycle of JC virus as potential therapeutic targets for the treatment of progressive multifocal leukoencephalopathy.
Baum S; Ashok A; Gee G; Dimitrova S; Querbes W; Jordan J; Atwood WJ
J Neurovirol; 2003; 9 Suppl 1():32-7. PubMed ID: 12709869
[TBL] [Abstract][Full Text] [Related]
5. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.
Ferenczy MW; Marshall LJ; Nelson CD; Atwood WJ; Nath A; Khalili K; Major EO
Clin Microbiol Rev; 2012 Jul; 25(3):471-506. PubMed ID: 22763635
[TBL] [Abstract][Full Text] [Related]
6. Update on progressive multifocal leukoencephalopathy.
Steiner I; Berger JR
Curr Neurol Neurosci Rep; 2012 Dec; 12(6):680-6. PubMed ID: 22991070
[TBL] [Abstract][Full Text] [Related]
7. Deep-Sequence Identification and Role in Virus Replication of a JC Virus Quasispecies in Patients with Progressive Multifocal Leukoencephalopathy.
Takahashi K; Sekizuka T; Fukumoto H; Nakamichi K; Suzuki T; Sato Y; Hasegawa H; Kuroda M; Katano H
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795410
[TBL] [Abstract][Full Text] [Related]
8. Interferon beta1-a and selective anti-5HT(2a) receptor antagonists inhibit infection of human glial cells by JC virus.
O'Hara BA; Atwood WJ
Virus Res; 2008 Mar; 132(1-2):97-103. PubMed ID: 18093678
[TBL] [Abstract][Full Text] [Related]
9. A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
Lee P; Plavina T; Castro A; Berman M; Jaiswal D; Rivas S; Schlain B; Subramanyam M
J Clin Virol; 2013 Jun; 57(2):141-6. PubMed ID: 23465394
[TBL] [Abstract][Full Text] [Related]
10. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy.
Beck ES; Cortese I
Curr Opin Virol; 2020 Feb; 40():19-27. PubMed ID: 32279025
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of mefloquine efficacy against JC virus in vitro.
Brickelmaier M; Lugovskoy A; Kartikeyan R; Reviriego-Mendoza MM; Allaire N; Simon K; Frisque RJ; Gorelik L
Antimicrob Agents Chemother; 2009 May; 53(5):1840-9. PubMed ID: 19258267
[TBL] [Abstract][Full Text] [Related]
12. Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region.
Mubanga E; Patel A; Siddiqi OK; Hanson BA; Dang X; Lakhi S; Mulundu G; Bender N; Koralnik IJ
J Neurovirol; 2019 Aug; 25(4):475-479. PubMed ID: 31028690
[TBL] [Abstract][Full Text] [Related]
13. Interferon- alpha and - beta restrict polyomavirus JC replication in primary human fetal glial cells: implications for progressive multifocal leukoencephalopathy therapy.
Co JK; Verma S; Gurjav U; Sumibcay L; Nerurkar VR
J Infect Dis; 2007 Sep; 196(5):712-8. PubMed ID: 17674314
[TBL] [Abstract][Full Text] [Related]
14. Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: a clinical, neuroradiological and virological response after treatment with risperidone.
Focosi D; Fazzi R; Montanaro D; Emdin M; Petrini M
Antiviral Res; 2007 May; 74(2):156-8. PubMed ID: 17140673
[TBL] [Abstract][Full Text] [Related]
15. IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression.
De-Simone FI; Sariyer R; Otalora YL; Yarandi S; Craigie M; Gordon J; Sariyer IK
PLoS One; 2015; 10(6):e0129694. PubMed ID: 26061652
[TBL] [Abstract][Full Text] [Related]
16. Progressive multifocal leukoencephalopathy: new concepts.
Lima MA
Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508
[TBL] [Abstract][Full Text] [Related]
17. Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).
Khalili A; Craigie M; Donadoni M; Sariyer IK
J Neuroimmune Pharmacol; 2019 Dec; 14(4):649-660. PubMed ID: 31452013
[TBL] [Abstract][Full Text] [Related]
18. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.
Lima MA; Marzocchetti A; Autissier P; Tompkins T; Chen Y; Gordon J; Clifford DB; Gandhi RT; Venna N; Berger JR; Koralnik IJ
J Virol; 2007 Apr; 81(7):3361-8. PubMed ID: 17229701
[TBL] [Abstract][Full Text] [Related]
19. Management of infections by the human polyomavirus JC: past, present and future.
Hou J; Major E
Expert Rev Anti Infect Ther; 2005 Aug; 3(4):629-40. PubMed ID: 16107201
[TBL] [Abstract][Full Text] [Related]
20. Natalizumab and progressive multifocal leukoencephalopathy: highlights of the International Workshop on JC Virus/PML and Multiple Sclerosis, June 3-4, 2005, Philadelphia PA.
Tyler KL; Khalili K
Rev Neurol Dis; 2005; 2(3):144-9. PubMed ID: 16400315
[No Abstract] [Full Text] [Related]
[Next] [New Search]
